Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)
Lian Liu, Nicole Tonya Erickson, Ingrid Ricard, Ludwig Fischer von Weikersthal, Markus M. Lerch, Thomas Decker, Alexander Kiani, Florian Kaiser, Tobias Heintges, Christoph Kahl, Frank Kullmann, Werner Scheithauer, Hartmut Link, Heinz Gert Höffkes, Markus Moehler, Alena Britta Gesenhues, Sebastian Theurich, Marlies Michl, Dominik P. Modest, Hana AlgülSebastian Stintzing, Volker Heinemann, Julian W. Holch
Research output: Contribution to journal › Article › peer-review
11Scopus
citations
Fingerprint
Dive into the research topics of 'Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)'. Together they form a unique fingerprint.